Supporting Care Partners' Well-Being With Artificial Intelligence (AI) Chatbots
Not Applicable
Not yet recruiting
- Conditions
- Caregivers
- Registration Number
- NCT07145723
- Lead Sponsor
- University of Michigan
- Brief Summary
This study is being completed to test an AI therapy chatbot application called Earkick to see whether it is feasible and acceptable in supporting care partners who support individuals living with dementia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Participants need to be a care partner (informal caregiver) of an individual living with dementia
- Participant provides emotional, physical, and/or financial support/assistance to the individual with dementia (per protocol)
- Participants indicate high levels of caregiver burden, confirmed using the 12-item Zarit Burden questionnaire (per protocol)
- Provide informed consent and read, speak, and understand English
- Have an Apple smartphone, tablet, or laptop, have access to the internet and text messages, and be willing to use this device as well as internet and text message access for the study, including downloading the AI chatbot app
- Be willing to complete all study assessments
Exclusion Criteria
- Professional, paid caregivers
- Anything that would preclude safe or meaningful participation in the study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Feasibility and Acceptability as measured by the Feasibility and Acceptability Questionnaire 4 weeks and 8 weeks (post intervention) Feasibility and Acceptability Questionnaire (items are scaled from 1 to 5 to indicate level of agreement, where "1" indicates "strong disagreement" and "5" indicates "strong agreement").
- Secondary Outcome Measures
Name Time Method Attrition as measured by the percent of participants completing the study 8 weeks Adherence as measured by the percentage of missing data over the course of the study 8 weeks
Trial Locations
- Locations (1)
University of Michigan
🇺🇸Ann Arbor, Michigan, United States
University of Michigan🇺🇸Ann Arbor, Michigan, United StatesRongqi BeiContactrbei@umich.eduMark Newman, PhDPrincipal Investigator